Cargando…

Health economic evaluation of dipeptidyl peptidase-4 inhibitors

Detalles Bibliográficos
Autor principal: Garg, Vishvas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152190/
https://www.ncbi.nlm.nih.gov/pubmed/21847463
http://dx.doi.org/10.4103/2230-8210.83049
_version_ 1782209745684267008
author Garg, Vishvas
author_facet Garg, Vishvas
author_sort Garg, Vishvas
collection PubMed
description
format Online
Article
Text
id pubmed-3152190
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31521902011-08-16 Health economic evaluation of dipeptidyl peptidase-4 inhibitors Garg, Vishvas Indian J Endocrinol Metab Letters to the Editor Medknow Publications 2011-07 /pmc/articles/PMC3152190/ /pubmed/21847463 http://dx.doi.org/10.4103/2230-8210.83049 Text en © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Garg, Vishvas
Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title_full Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title_fullStr Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title_full_unstemmed Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title_short Health economic evaluation of dipeptidyl peptidase-4 inhibitors
title_sort health economic evaluation of dipeptidyl peptidase-4 inhibitors
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152190/
https://www.ncbi.nlm.nih.gov/pubmed/21847463
http://dx.doi.org/10.4103/2230-8210.83049
work_keys_str_mv AT gargvishvas healtheconomicevaluationofdipeptidylpeptidase4inhibitors